por
Li, Yansong,
Chavko, Mikulas,
Slack, Jessica L,
Liu, Bin,
McCarron, Richard M,
Ross, James D,
Dalle Lucca, Jurandir J
Publicado 2013
“…Administration of rhDAF after exposure to moderate blast overpressure (BOP, 120 kPa) mitigated brain injury characterized by neuronal degeneration. rhDAF treatment reduced complement hemolytic activity at 3 hours and tissue complement deposition at 3, 24, and 48 hours as well as systemic and local cytokine release at 24 hours
post BOP. Furthermore, rhDAF protected blood–brain barrier (BBB) integrity and reduced cytotoxic edema. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto